This site is still under development. Information, features, and some organizational
aspects of the data still need further work and will change as we continue building.

Islet Cell Carcinoma

Hover over a term you want explained. If you need more details, then click on the term and a new tab will open with a full details page.

What Islet Cell Carcinoma Means

Islet cell carcinoma, also called pancreatic endocrine cancer, is a rare type of cancer that starts in the islet cells of the pancreas. These islet cells are special hormone-producing cells that help control important body functions such as blood sugar levels and digestion. Unlike the more common pancreatic cancers that begin in cells producing digestive juices, islet cell carcinoma arises from cells that release hormones into the bloodstream.

Some islet cell tumors produce extra hormones, which can cause symptoms related to hormone imbalances, such as low or high blood sugar or digestive problems. These are called functional tumors. Others do not produce extra hormones and are called nonfunctional tumors; they may only cause symptoms as they grow larger or spread to other parts of the body.

Why This Concept Can Matter in Cancer Care

Because islet cell carcinoma is rare and different from the more common pancreatic cancers, it may have a different outlook and treatment approach. Knowing whether the tumor is functional or nonfunctional helps doctors understand what symptoms to expect and how best to manage the disease. Functional tumors may cause symptoms earlier due to hormone effects, while nonfunctional tumors might be found later when they grow or spread.

Understanding this cancer type helps guide treatment decisions and symptom management. Patients may have questions about hormone-related symptoms or how the tumor’s behavior affects their care plan.

What Patients Might See or Hear About This Term

Patients might hear the terms “islet cell carcinoma,” “pancreatic endocrine cancer,” or “pancreatic neuroendocrine tumor.” These terms all refer to cancers starting in the hormone-producing cells of the pancreas. Medical reports, treatment plans, or clinical trial information may use these names.

Because these cancers are less common, patients may find information confusing or limited. It’s important to ask the healthcare team about the specific tumor type, whether it produces hormones, and what symptoms to watch for. Symptoms can vary widely, and some patients may have no symptoms at first.

What This Term Does Not Automatically Mean

Hearing “islet cell carcinoma” does not automatically mean the cancer is advanced or that symptoms will be severe. Some tumors grow slowly and may be found early. Also, this term refers only to a specific kind of pancreatic cancer and does not include the more common types that start in other pancreatic cells.

Not all pancreatic cancers behave the same way, so it’s important not to assume the diagnosis or outlook based on this term alone.

How Doctors Use This Term in Care

Doctors use the term islet cell carcinoma to describe the type of tumor during diagnosis and to guide treatment decisions. Tests may be done to see if the tumor is making extra hormones, which can affect symptoms and treatment choices. Imaging tests, blood tests, and biopsies help determine the tumor’s nature.

Knowing if the tumor is functional or nonfunctional helps doctors plan treatments and monitor for hormone-related symptoms. This information also helps in discussing prognosis and possible clinical trials.

Common Sources of Confusion

Because pancreatic cancers can start in different types of cells, patients may confuse islet cell carcinoma with the more common pancreatic adenocarcinoma. The terms “pancreatic endocrine cancer,” “islet cell tumor,” and “pancreatic neuroendocrine tumor” are often used interchangeably, which can add to confusion.

Also, some tumors produce hormones causing symptoms, while others do not, so symptoms alone may not clearly indicate the tumor type. Patients should ask their care team to explain what the terms mean in their specific case.

Practical Questions to Ask Your Care Team

Patients and caregivers might ask: What type of islet cell tumor do I have? Is it functional or nonfunctional? What symptoms should I watch for? How will this affect my treatment options? Are there clinical trials available for this type of cancer? What can I expect in terms of monitoring and follow-up?

Understanding the Term in Context

Islet cell carcinoma is one specific kind of pancreatic cancer that involves hormone-producing cells. It is important to understand this term as part of the overall diagnosis and treatment plan, rather than in isolation. Discussing the term with your healthcare team can help clarify what it means for your care.

Safety and Next Steps

This information is meant to help patients and caregivers understand what islet cell carcinoma means and how it might affect care. It is not a substitute for medical advice. If you or a loved one has been diagnosed with this cancer, the next step is to talk with your healthcare team about your specific tumor type, whether it produces hormones, and what treatments are recommended. Learning about this cancer type can help you feel more informed and prepared for your care journey.

Sources

Public source information used for this glossary entry includes: